Arrhythmia Research Technology, Inc. · Fitchburg, MA United States ·(NYSE Alternext: HRT)
Company Description
This link will open in a new window It's all about heart for Arrhythmia Research Technology (ART). The company offers signal-averaging electrocardiographic (SAECG) software that collects data and analyzes electrical impulses of the heart in an effort to detect potentially lethal heart arrhythmias. The company plans to sell the products through licensing agreements with equipment makers. Until it finds a marketing partner, however, ART is relying on sales from its Micron Products subsidiary, which makes snaps and sensors used in the manufacture and operation of disposable electrodes for electrocardiographic (ECG) equipment. Micron Products has acquired assets of several companies that enhance its metal and plastics molding capabilities. To read the full description, subscribe now.
Key Arrhythmia Research Technology, Inc. Financials
| Company Type | Public - NYSE Alternext: HRT Headquarters |
| Fiscal Year-End | December |
| 2008 Sales (mil.) | $22.5 |
| 2008 Employees | 85 |
Arrhythmia Research Technology, Inc. Executives
| Title | Name & Bio | Contact |
| Chairman | E. P. Marinos | Network |
| President, CEO, and Director | James Rouse | Network |
| EVP Finance and CFO | David Garrison | Network |